← ANALYST RATINGS · TIPRANKS

HCA Healthcare (HCA): analyst forecast and price target

$459 −2.06% close 16.10.26 · market cap $101B · Healthcare · Medical - Care Facilities SPY 0.10%
Price targets and ratings of

Analyst consensus

Moderate Buy

13 Buy7 Hold1 Sell

Ratings of 21 analysts in the last 3 months

12-month forecast

$455−0.8% downside

Based on 21 price targets given in the last 3 months, the average target is $455, the highest $579, the lowest $380. The average is −0.8% from the last price of $459.

$400$500Jan 26AprJulOctJan 27AprJulOctHigh$579Average$455Low$380
Highest target $579 Average target $455 Lowest target $380
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% TD Cowen $431 → $460+6.7% Buy +0.3% Reiterated 12.10.26on TipRanks 08:10 +1.7%next day +0.5%
Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% RBC Capital $435 → $496+14.0% Buy +8.1% Reiterated 07.10.26on TipRanks 08:31 +1.9%next day +1.8% · 5 days +8.1%
Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% Barclays $387 Hold −15.7% Reiterated 07.10.26on TipRanks 04:00 +1.9%next day +1.8% · 5 days +8.1%
Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% Bernstein $426 Hold −7.2% Reiterated 05.10.26on TipRanks 07:31 +1.3%next day −1.2% · 5 days +5.0%
Andrew Cooper★★★★★★★★★★#11107 · hits 40% · avg −3.0% Raymond James — Hold — Reiterated 28.09.26on TipRanks 09:00 +0.1%next day 0.0% · 5 days −0.7%
Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% BMO Capital $495 Buy +7.9% Initiated 22.09.26on TipRanks 16:40 +0.3%next day −2.9% · 5 days −1.6%
Whit Mayo★★★★★★★★★★#3228 · hits 49% · avg +3.6% Leerink Partners — Buy — Reiterated 17.09.26on TipRanks Sep 18 04:20 −1.5%next day −0.4% · 5 days −2.1%
Brian Tanquilut★★★★★★★★★★#1681 · hits 52% · avg +6.6% Jefferies $450 Buy −1.9% Reiterated 17.09.26on TipRanks 09:26 −1.5%next day −0.4% · 5 days −2.1%
Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% Bernstein $426 Hold −7.2% Reiterated 09.09.26on TipRanks 06:35 +5.4%next day +0.5% · 5 days +3.3%
Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% RBC Capital $435 Buy −5.2% Reiterated 07.09.26on TipRanks Sep 8 08:45 −0.2%next day +5.4% · 5 days +6.5%
Benjamin Rossi★★★★★★★★★★#2996 · hits 75% · avg +16.8% J.P. Morgan $425 Hold −7.4% Reiterated 24.08.26on TipRanks Aug 25 08:09 +0.3%next day −0.4% · 5 days −3.9%
Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% Bank of America Securities $400 → $425+6.2% Hold −7.4% Reiterated 10.08.26on TipRanks 05:16 +0.2%next day −0.3% · 5 days −2.1%
David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% Argus Research $500 Buy +9.0% Assigned 07.08.26on TipRanks Aug 10 09:15 +0.5%next day +0.2% · 5 days −2.5%
David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% Truist Financial $495 Buy +7.9% Reiterated 05.08.26on TipRanks 07:55 +2.4%next day 0.0% · 5 days +0.9%
Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% Wells Fargo $369 → $381+3.3% Hold −17.0% Assigned 03.08.26on TipRanks 07:01 −0.4%next day −3.2% · 5 days −0.2%
Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% Mizuho Securities $525 → $475−9.5% Buy +3.5% Reiterated 28.07.26on TipRanks 08:00 +7.1%next day −0.9% · 5 days −8.3%
Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% Goldman Sachs $558 → $485−13.1% Buy +5.7% Reiterated 27.07.26on TipRanks Jul 28 06:10 +1.9%next day +7.1% · 5 days +1.8%
A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% UBS $635 → $579−8.8% Buy +26.2% Reiterated 27.07.26on TipRanks 11:28 +1.9%next day +7.1% · 5 days +1.8%
Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% Robert W. Baird $396 → $393−0.8% Hold −14.3% Reiterated 27.07.26on TipRanks 09:10 +1.9%next day +7.1% · 5 days +1.8%
Pito Chickering★★★★★★★★★★#1500 · hits 61% · avg +9.8% Deutsche Bank $540 → $476−11.9% Buy +3.7% Assigned 27.07.26on TipRanks 09:10 +1.9%next day +7.1% · 5 days +1.8%
Craig Hettenbach★★★★★★★★★★#1537 · hits 59% · avg +7.6% Morgan Stanley $425 → $380−10.6% Sell −17.2% Reiterated 27.07.26on TipRanks 09:10 +1.9%next day +7.1% · 5 days +1.8%
Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% Oppenheimer $520 → $485−6.7% Buy +5.7% Reiterated 27.07.26on TipRanks 09:10 +1.9%next day +7.1% · 5 days +1.8%
Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% KeyBanc $475 → $435−8.4% Buy −5.2% Reiterated 27.07.26on TipRanks 09:10 +1.9%next day +7.1% · 5 days +1.8%
Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% TD Cowen $431 Buy −6.1% Assigned 27.07.26on TipRanks 09:10 +1.9%next day +7.1% · 5 days +1.8%
Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% Barclays $402 → $387−3.7% Hold −15.7% Reiterated 26.07.26on TipRanks Jul 27 09:10 +1.9%next day +7.1% · 5 days +1.8%
Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% Cantor Fitzgerald $525 Buy +14.4% Reiterated 14.07.26on TipRanks 09:40 −7.3%next day +3.8% · 5 days +3.1%
Raj Kumar CFA★★★★★★★★★★#3375 · hits 77% · avg +21.7% Stephens $530 Buy +15.5% Assigned 27.04.26on TipRanks 09:15 +2.9%next day −2.6% · 5 days −4.6%
Jason Cassorla★★★★★★★★★★#3435 · hits 57% · avg +5.7% Guggenheim — Hold — Reiterated 27.01.26on TipRanks Jan 28 06:55 +6.7%next day −2.9% · 5 days −0.5%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering HCA Healthcare

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Sarah James★★★★★★★★★★Cantor Fitzgerald · #2265
Hits 55%182 of 330 Average return +5.7%
1 year Sarah James★★★★★★★★★★Cantor Fitzgerald · #2265
Hits 55%182 of 330 Average return +5.7%
2 years Whit Mayo★★★★★★★★★★Leerink Partners · #3228
Hits 49%220 of 445 Average return +3.6%

Most profitable

3 months Sarah James★★★★★★★★★★Cantor Fitzgerald · #2265
Hits 55%182 of 330 Average return +5.7%
1 year David S Macdonald★★★★★★★★★★Truist Financial · #400
Hits 63%312 of 499 Average return +13.2%
2 years Whit Mayo★★★★★★★★★★Leerink Partners · #3228
Hits 49%220 of 445 Average return +3.6%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $454 at a price of $427 (+6.4%); now: $455 at $459 (−0.8%).

$400$420$440$460Sep 15Oct 1Oct 15Top analysts$466Average target$455Price$459

PriceAverage targetTop analysts’ target

Recommendation trend

0204030131Oct 252712Nov259Dec17112Jan 2621112Feb22112Mar179Apr159May1611Jun125152Jul125192Aug126192Sep911Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy001110
Buy15162525269
Hold91115191911
Sell002220

Earnings and sales forecast

Next report: 27.10.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $6.66 (from $5.83 to $7.35). Last quarter: $7.59.

Sales

Next quarter’s sales estimate — $19.3B (from $18.8B to $19.9B). Last quarter: $20.2B.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About HCA Healthcare

HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.

Data from the stock’s TipRanks forecast page, read 17 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗